Feburic Prevents Cerebral, Cardiorenovascular Events: Japan Multicenter Study

March 13, 2019
The hyperuricemia treatment febuxostat, known as Feburic, is effective for reducing cerebral, cardiac, and renal vascular events in elderly patients with hyperuricemia, a Japan multicenter study has revealed. This is the world’s first study to prove the efficacy of febuxostat...read more